Voleon Capital Management’s Exact Sciences EXAS Stock Holding History

Voleon Capital Management’s Portfolio EXAS Stock Details EXAS Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q1	–	Sell	-10,532	Closed	-$1.07M	–	831
2025 Q4	$1.07M	Buy	10,532 +5,633	+115%	+$452K	0.02%	427
2025 Q3	$268K	Buy	+4,899	New	+$245K	0.01%	756

Other funds holding EXAS

VanEck Associates

VanEck Associates New York $133B AUM 72.99% 1-Year Est. Return

Wealth Enhancement Advisory Services

Wealth Enhancement Advisory Services Plymouth, Minnesota $59.8B AUM 29.42% 1-Year Est. Return

Pinkerton Retirement Specialists Coeur D Alene, Idaho $1.1B AUM 30.57% 1-Year Est. Return

Pinnacle Wealth Management Advisory Group Red Bank, New Jersey $1.46B AUM 22.77% 1-Year Est. Return

IFP Advisors Tampa, Florida $5.54B AUM 27.43% 1-Year Est. Return

Huntington National Bank Columbus, Ohio $18.1B AUM 24.69% 1-Year Est. Return

Broadwater Capital Boston, Massachusetts $138M AUM 28.86% 1-Year Est. Return

Voleon Capital Management's EXAS Position: Q1 2026 in Review

Voleon Capital Management sold out of Exact Sciences (EXAS) in Q1 2026, closing a stake of 10,532 shares — an estimated $1.07M sold.

Voleon Capital Management first reported a position in EXAS in Q3 2025 and held it in 2 quarters. The position peaked at $1.07M in Q4 2025. 7 funds tracked by Wall St. Rank hold EXAS as of Q1 2026.

Voleon Capital Management reported no remaining Exact Sciences position as of Q1 2026 after selling out during the quarter.
Voleon Capital Management sold 10,532 Exact Sciences shares in Q1 2026, an estimated $1.07M.
Voleon Capital Management first reported a position in Exact Sciences in Q3 2025 and held it in 2 quarters.
Voleon Capital Management's Exact Sciences position peaked at $1.07M in Q4 2025.
7 funds tracked by Wall St. Rank held Exact Sciences as of Q1 2026.

Based on Voleon Capital Management's 13F filing for Q1 2026, filed 15 May 2026.